BFC Planning’s bioAffinity Technologies BIAF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-11
Closed -$135 – 3482
2026
Q2
$135 Hold
11
– – ﹤0.01% 3338
2026
Q1
$636 Hold
11
– – ﹤0.01% 2817
2025
Q4
$196 Hold
11
– – ﹤0.01% 3037
2025
Q3
$491 Buy
+11
New +$1.31K ﹤0.01% 2751
2025
Q2
– Sell
-4
Closed -$520 – 2682
2025
Q1
$520 Hold
4
– – ﹤0.01% 2513
2024
Q4
$1.82K Buy
4
+2
+100% +$1.21K ﹤0.01% 2303
2024
Q3
$2.08K Buy
+2
New +$1.8K ﹤0.01% 2270

Other funds holding BIAF

BFC Planning's BIAF Position: Q3 2026 in Review

BFC Planning sold out of bioAffinity Technologies (BIAF) in Q3 2026, closing a stake of 11 shares — an estimated $135 sold.

BFC Planning first reported a position in BIAF in Q3 2024 and held it in 7 quarters. The position peaked at $2.08K in Q3 2024. 9 funds tracked by Wall St. Rank hold BIAF as of Q3 2026.

  • BFC Planning reported no remaining bioAffinity Technologies position as of Q3 2026 after selling out during the quarter.
  • BFC Planning sold 11 bioAffinity Technologies shares in Q3 2026, an estimated $135.
  • BFC Planning first reported a position in bioAffinity Technologies in Q3 2024 and held it in 7 quarters.
  • BFC Planning's bioAffinity Technologies position peaked at $2.08K in Q3 2024.
  • 9 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.